Vanguard Group Discloses Position in Spire Healthcare

The Vanguard Group, Inc. has filed a Form 8.3 for Spire Healthcare Group plc, disclosing its interest in relevant securities representing over 1% as per Rule 8.3 of the Takeover Code. As of November 12, 2026, Vanguard owns and controls 14,439,360 of Spire's ordinary 1p shares, equating to a 3.59% stake.

The disclosure includes a recent purchase of 572 ordinary shares at 2.47 GBP per share. Vanguard has not entered any cash or stock-settled derivative positions nor made agreements regarding options or derivatives on these securities. There are no indemnity or other dealing arrangements reported.

Vanguard confirms no supplemental Form 8 is included, indicating no additional open positions. The disclosure was made on November 13, 2026, with contact details provided for further inquiries.